JPWO2021261444A5 - - Google Patents

Download PDF

Info

Publication number
JPWO2021261444A5
JPWO2021261444A5 JP2022531976A JP2022531976A JPWO2021261444A5 JP WO2021261444 A5 JPWO2021261444 A5 JP WO2021261444A5 JP 2022531976 A JP2022531976 A JP 2022531976A JP 2022531976 A JP2022531976 A JP 2022531976A JP WO2021261444 A5 JPWO2021261444 A5 JP WO2021261444A5
Authority
JP
Japan
Prior art keywords
tetradecanoyl
oxy
pharma
acceptable salt
decanoyloxy
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2022531976A
Other languages
English (en)
Japanese (ja)
Other versions
JPWO2021261444A1 (https=
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/JP2021/023402 external-priority patent/WO2021261444A1/ja
Publication of JPWO2021261444A1 publication Critical patent/JPWO2021261444A1/ja
Publication of JPWO2021261444A5 publication Critical patent/JPWO2021261444A5/ja
Withdrawn legal-status Critical Current

Links

JP2022531976A 2020-06-22 2021-06-21 Withdrawn JPWO2021261444A1 (https=)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2020107194 2020-06-22
PCT/JP2021/023402 WO2021261444A1 (ja) 2020-06-22 2021-06-21 Tlr4作動活性を有するアジュバント

Publications (2)

Publication Number Publication Date
JPWO2021261444A1 JPWO2021261444A1 (https=) 2021-12-30
JPWO2021261444A5 true JPWO2021261444A5 (https=) 2024-06-25

Family

ID=79281148

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022531976A Withdrawn JPWO2021261444A1 (https=) 2020-06-22 2021-06-21

Country Status (15)

Country Link
US (1) US20230287027A1 (https=)
EP (1) EP4169527A4 (https=)
JP (1) JPWO2021261444A1 (https=)
KR (1) KR20230026438A (https=)
CN (1) CN116056721A (https=)
AU (1) AU2021295796A1 (https=)
BR (1) BR112022025969A2 (https=)
CA (1) CA3187828A1 (https=)
CL (1) CL2022003689A1 (https=)
IL (1) IL299253A (https=)
MX (1) MX2022016181A (https=)
PE (1) PE20230463A1 (https=)
PH (1) PH12022553464A1 (https=)
SA (1) SA522441781B1 (https=)
WO (1) WO2021261444A1 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2026018889A1 (ja) * 2024-07-19 2026-01-22 住友ファーマ株式会社 ワクチンアジュバントを含むリポソーム製剤

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6113918A (en) 1997-05-08 2000-09-05 Ribi Immunochem Research, Inc. Aminoalkyl glucosamine phosphate compounds and their use as adjuvants and immunoeffectors
US6303347B1 (en) 1997-05-08 2001-10-16 Corixa Corporation Aminoalkyl glucosaminide phosphate compounds and their use as adjuvants and immunoeffectors
ATE518874T1 (de) 1999-11-15 2011-08-15 Oncothyreon Inc Synthetische lipid-a analogen und verwendungen davon
CN101863930A (zh) 2003-01-06 2010-10-20 科里克萨有限公司 一些氨烷基氨基葡糖苷磷酸酯化合物和它们的用途
US7807720B2 (en) 2007-02-01 2010-10-05 Panthera Biopharma, Llc Hydroxamic acid derivatives of 3-phenyl propionic acids useful as therapeutic agents for treating anthrax poisoning
CN105188710A (zh) * 2013-03-15 2015-12-23 葛兰素史密丝克莱恩生物有限公司 包含缓冲的氨基烷基氨基葡糖苷磷酸酯衍生物的组合物及其用于增强免疫应答的用途
EP3242883A4 (en) * 2015-01-06 2018-10-17 ImmunoVaccine Technologies Inc. Lipid a mimics, methods of preparation, and uses thereof
JP7362667B2 (ja) * 2018-02-12 2023-10-17 イニミューン・コーポレーション Toll様受容体リガンド

Similar Documents

Publication Publication Date Title
JP2021514001A5 (https=)
JP2021526133A5 (https=)
JP2007502804A5 (https=)
JP2024504932A5 (https=)
JP2022536728A5 (https=)
RU2004104625A (ru) Аналоги простагландинов в качестве агонистов рецептора ep4
JP2010540525A5 (https=)
JP2024522990A5 (https=)
JP2021534124A5 (https=)
JP2013534248A5 (https=)
JPWO2022014639A5 (https=)
JP2020515610A5 (https=)
JP2015518004A5 (https=)
JP2022137237A5 (https=)
JP2017518959A5 (https=)
RU2009102278A (ru) Модуляторы рецептора s1p для лечения рассеянного склероза
RU2007147344A (ru) Новые производные 2-азетидинона для лечения гиперлипидемических заболеваний
JP2010526801A5 (https=)
JP2020532546A5 (https=)
JP2014519507A5 (https=)
JP2013526520A5 (https=)
JP2011517697A5 (https=)
JPWO2021261444A5 (https=)
JP2024501257A5 (https=)
RU2007147340A (ru) Новые производные 2-азетидинона в качестве ингибиторов всасывания холестерина для лечения гиперлипидемических состояний